Evidence map›Paper›PMID 37023360›Full record

ArticleSchizophrenia bulletin2023

Review of Major Social Determinants of Health in Schizophrenia-Spectrum Psychotic Disorders: III. Biology.

Dilip V Jeste, Dolores Malaspina, Kara Bagot, Deanna M Barch, Steve Cole, Faith Dickerson, Amanda Dilmore, Charles L Ford, Nicole R Karcher, Joan Luby and 3 more

Open access · bronzeAbstract readComment
In one paragraph

Article in Schizophrenia bulletin, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Schizophrenia: A Review of Social Risk Factors That Affect Women.Behavioral sciences (Basel, Switzerland) · 2023
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 3 countries.

Dilip V JesteDepartment of Psychiatry, University of California, San Diego (Retired), CA, USA.
Dolores MalaspinaDepartments of Psychiatry, Neuroscience and Genetics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Kara BagotDepartment of Psychiatry, Addiction Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Deanna M BarchDepartments of Psychological and Brain Sciences, Psychiatry, and Radiology, Washington University in St. Louis, St. Louis, MO, USA.ORCID 0000-0003-1693-8506
Steve ColeDepartments of Psychiatry and Biobehavioral Sciences, and Medicine, University of California, Los Angeles, CA, USA.
Faith DickersonDepartment of Psychology, Sheppard Pratt, Baltimore, MD, USA.
Amanda DilmoreDepartment of Pediatrics, University of California, San Diego, CA, USA.
Charles L FordCenter for Translational Social Neuroscience, Department of Psychiatry, Emory University, Atlanta, GA, USA.
Nicole R KarcherDepartment of Psychiatry, Washington University in St. Louis, St. Louis, MO, USA.ORCID 0000-0001-5887-5529
Joan LubyDepartment of Psychiatry (Child), Washington University in St. Louis, St. Louis, MO, USA.
Tarek RajjiAdult Neurodevelopment and Geriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Adrián A Pinto-TomasBiochemistry Department, School of Medicine, Universidad de Costa Rica, San José, Costa Rica.
Larry J YoungCenter for Translational Social Neuroscience, Department of Psychiatry, Emory University, Atlanta, GA, USA.
Washington University in St. Louis · USEmory University · USIcahn School of Medicine at Mount Sinai · USUniversity of California San Diego · USCentre for Addiction and Mental Health · CASheppard and Enoch Pratt Hospital · USUniversidad de Costa Rica · CRUniversity of California, Los Angeles · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Adolescent Substance Use Initiation: Disentangling neurocognitive risks from consequences using longitudinal and genetically-informed methodsU01DA041120 · NIDA · UNIVERSITY OF MINNESOTA · PI Monica Luciana, Sylia Wilson · 2015 to 2026
$34.5M
The Impact of Oxytocin on the Neural Representation Social Stimuli P50MH100023 · NIMH · EMORY UNIVERSITY · PI YOUNG, LARRY J · 2013 to 2022
$21.8M
Early Life Adversity, Biological Embedding, and Risk for Developmental Precursors of Mental DisordersR01MH113883 · NIMH · WASHINGTON UNIVERSITY · PI JOAN L. LUBY, Christopher Daniel Smyser · 2018 to 2026
$20.6M
African Ancestry Genomic Psychiatry CohortR01MH104964 · NIMH · SUNY DOWNSTATE MEDICAL CENTER · PI BIGDELI, TIM BERNARD, FANOUS, AYMAN H · 2015 to 2024
$16.7M
Accelerated Inflammaging in SchizophreniaR01MH094151 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI EYLER, LISA T · 2012 to 2021
$7.4M
Medical Scientist Training ProgramT32GM142617 · NIGMS · EMORY UNIVERSITY · PI Jason Yustein · 2022 to 2026
$7.0M
Schizophrenia, Prefrontal Cortex, and Emotion RegulationR01MH066031 · NIMH · WASHINGTON UNIVERSITY · PI BARCH, DEANNA · 2004 to 2014
$4.1M
Hippocampal Inflammation as a Pathophysiology for PsychosisR01MH110418 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MALASPINA, DOLORES · 2017 to 2021
$3.8M
Cross-sectional and longitudinal predictors of distressing psychotic-like experiences in childhood and adolescenceK23MH121792 · NIMH · WASHINGTON UNIVERSITY · PI KARCHER, NICOLE R. · 2020 to 2024
$815k
NIDA NIH HHS U01 DA041120NIGMS NIH HHS T32 GM142617NIH HHS MH110418NIH HHS P51 OD011132NIMH NIH HHS 2R01MH094151-08NIMH NIH HHS K23 MH121792NIMH NIH HHS P50 MH100023NIMH NIH HHS R01 MH066031NIMH NIH HHS R01 MH094151NIMH NIH HHS R01 MH104964NIMH NIH HHS R01 MH110418NIMH NIH HHS R01 MH113883
6 · The paper itself

Abstract

backgroundSocial determinants of health (SDoHs) are nonmedical factors that significantly impact health and longevity. We found no published reviews on the biology of SDoHs in schizophrenia-spectrum psychotic disorders (SSPD). STUDY

designWe present an overview of pathophysiological mechanisms and neurobiological processes plausibly involved in the effects of major SDoHs on clinical outcomes in SSPD. STUDY

resultsThis review of the biology of SDoHs focuses on early-life adversities, poverty, social disconnection, discrimination including racism, migration, disadvantaged neighborhoods, and food insecurity. These factors interact with psychological and biological factors to increase the risk and worsen the course and prognosis of schizophrenia. Published studies on the topic are limited by cross-sectional design, variable clinical and biomarker assessments, heterogeneous methods, and a lack of control for confounding variables. Drawing on preclinical and clinical studies, we propose a biological framework to consider the likely pathogenesis. Putative systemic pathophysiological processes include epigenetics, allostatic load, accelerated aging with inflammation (inflammaging), and the microbiome. These processes affect neural structures, brain function, neurochemistry, and neuroplasticity, impacting the development of psychosis, quality of life, cognitive impairment, physical comorbidities, and premature mortality. Our model provides a framework for research that could lead to developing specific strategies for prevention and treatment of the risk factors and biological processes, thereby improving the quality of life and increasing the longevity of people with SSPD.

conclusionsBiology of SDoHs in SSPD is an exciting area of research that points to innovative multidisciplinary team science for improving the course and prognosis of these serious psychiatric disorders.

Indexed as

Psychotic DisordersSchizophreniaBiologyCross-Sectional StudiesHumansQuality of LifeSocial Determinants of Healthepigeneticsmicrobiomeneurodevelopmentoxytocinracismsocial connections

Identifiers

PMID37023360
PMCPMC10318888
OpenAlexW4362659676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.